Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Vermeire

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Antiviral Therapy|February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
Viruses|April 28, 2023
A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV InfectionBirger Tielemans, Lander De Herdt, Emilie Pollenus, et al.
Frontiers in Chemistry|November 17, 2022
Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agentsBelén Martinez-Gualda, Mirthe Graus, Anita Camps, et al.
Virology|November 21, 2002
CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptorKurt Vermeire, Ying Zhang, Katrien Princen, et al.
Journal of Medicinal Chemistry|February 17, 2006
Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analoguesThomas W Bell, Sreenivasa Anugu, Patrick Bailey, et al.
Journal of Virology|August 22, 2008
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsOlivia Goethals, Reginald Clayton, Marcia Van Ginderen, et al.
Cell Reports|December 5, 2025
Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potencyMarijke Verhaegen, Marianne Croonenborghs, Nidhi Sorout, et al.
Plos Neglected Tropical Diseases|March 5, 2020
Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamicsBram Vrancken, Tony Wawina-Bokalanga, Bert Vanmechelen, et al.
Journal of Medicinal Chemistry|August 24, 2021
Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) CompoundsKaroline Berger, Eva Pauwels, Gabrielle Parkinson, et al.
Biochemical Pharmacology|October 21, 2018
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entryAnneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Antiviral Therapy|February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
Viruses|April 28, 2023
A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV InfectionBirger Tielemans, Lander De Herdt, Emilie Pollenus, et al.
Frontiers in Chemistry|November 17, 2022
Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agentsBelén Martinez-Gualda, Mirthe Graus, Anita Camps, et al.
Virology|November 21, 2002
CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptorKurt Vermeire, Ying Zhang, Katrien Princen, et al.
Journal of Medicinal Chemistry|February 17, 2006
Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analoguesThomas W Bell, Sreenivasa Anugu, Patrick Bailey, et al.
Journal of Virology|August 22, 2008
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsOlivia Goethals, Reginald Clayton, Marcia Van Ginderen, et al.
Cell Reports|December 5, 2025
Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potencyMarijke Verhaegen, Marianne Croonenborghs, Nidhi Sorout, et al.
Plos Neglected Tropical Diseases|March 5, 2020
Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamicsBram Vrancken, Tony Wawina-Bokalanga, Bert Vanmechelen, et al.
Journal of Medicinal Chemistry|August 24, 2021
Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) CompoundsKaroline Berger, Eva Pauwels, Gabrielle Parkinson, et al.
Biochemical Pharmacology|October 21, 2018
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entryAnneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, et al.
Pageof 9